The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...
(Scott Olson/Getty Images) In the final days of the Biden administration, the Foodand DrugAdministration proposed ... including the FDA and the Centers for Disease Control and Prevention ...